PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
30-May-2023 Dr. Rohtash Kumar Joins Veranova as Chief Technology Officer Veranova
30-May-2023 BioSenic provides update regarding current license agreement with Phebra BioSenic
30-May-2023 Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review HUTCHMED
30-May-2023 Heavy drinkers risk muscle loss, new study finds University of East Anglia
29-May-2023 Alfa Chemistry Offers Optical Brighteners, Plasticizers, and Antioxidants as Polymer Stabilizers Alfa Chemistry
24-May-2023 TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion TriLink BioTechnologies®
24-May-2023 Discovery Park and EKC Group join forces to boost STEM careers in Kent Discovery Park
23-May-2023 Flexicon’s integrated solution for Müggenburg Pharma's filling line increases capacity for high-value product Flexicon
23-May-2023 UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials Veeva Systems
23-May-2023 PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases PharmEnable
23-May-2023 Scarlet Therapeutics Announces Seed Financing to Advance Development of Therapeutic Red Blood Cell Platform Scarlet Therapeutics
23-May-2023 Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology Valo Therapeutics
23-May-2023 New SmiLe company Suturion plans to launch its surgical sewing machine this year Suturion
23-May-2023 Qlucore's software for cancer diagnostics on its way to obtaining CE certification Qlucore
23-May-2023 Molecular glues to tackle ‘undruggable’ disease targets Francis Crick Institute
23-May-2023 PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases PharmEnable
23-May-2023 BioSenic provides first quarter 2023 business update BioSenic
23-May-2023 Aptamer Group consortium awarded Eurostars grant to develop a novel prenatal disease diagnostic device Aptamer Group
23-May-2023 Alfa Chemistry’s Laboratory Increases Capability for Water Analysis, Resin Analysis, and Chromatography Analysis Alfa Chemistry
22-May-2023 Integra Therapeutics CEO Avencia Sánchez-Mejías to speak at Global Synthetic Biology Conference Integra Therapeutics